Germany to lead the Europe Prostate Cancer Market in 2022
Europe Prostate Cancer Market by Diagnostic Techniques, by Surgery, by Radiation Therapy and Brachytherapy, by Chemotherapy, and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
(EMAILWIRE.COM, November 28, 2017 ) According to the report Europe Prostate Cancer Market, published by Market Data Forecast, the Europe market is projected to reach USD 22 billion by 2022, at a CAGR of 9.1% from 2017 to 2022.
It is a commonly occurring type of cancer. In the last few years this market has grown by leaps and bounds with the metastatic castrate-resistant prostate cancer (mCRPC) situation becoming more and more crowded and competitive.
Get a comprehensive overview of the Europe Prostate Cancer Market: http://marketdataforecast.com/market-reports/europe-prostate-cancer-market-1618/
Europe Prostate Cancer Market: Drivers & Restraints
Increasing number of prostate cancer cases, augmenting geriatric population, rising demand for novel drugs and growing number of unmet needs are the primary restraints of market growth.
Hefty treatment costs and low compliance rate from the patients because of the intricacy of treatments are the primary restraint of the market.
Get accurate market forecast and analysis on the Europe Prostate Cancer Market. Request a sample to stay up-to-date on the main trends affecting this market: http://marketdataforecast.com/market-reports/europe-prostate-cancer-market-1618/request-sample
Europe Prostate Cancer Market: Segmentation
By Diagnostic Techniques
• Digital Rectal Exam (DRE)
• Prostate Specific Antigen Test (PSA)
By Surgery
• Radical Prostatectomy
• Orchidectomy
• Trans Urethral Resection (TUR)
By Radiation Therapy
• External Beam Radiation Therapy
o 3D Conformal Radiation Therapy
o Intensity Modulated Radiation Therapy
o Stereotactic Body Radiation Therapy
o Proton Beam Radiation Therapy
• Brachytherapy
o Permanent Brachytherapy
o Temporary Brachytherapy
By Chemotherapy
• Docetaxel
• Etoposide
• Vinblastine
• Carboplatin
• Vinorelbine
By Geography
• Europe
o China
o India
o Japan
o Australia
o South Korea
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://marketdataforecast.com/market-reports/europe-prostate-cancer-market-1618/customize-report
Europe Prostate Cancer Market: Overview
By radiation therapy, External Beam Radiation Therapy is the market leader and is expected to remain so in the aforementioned period.
Europe is the second largest market in the world. Germany is the market leader accounting for the largest market share and is expected to remain so in the aforementioned forecast period.
Europe Prostate Cancer Market: Key Players
Key players in the market include Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer. Other players in the market include Johnson & Johnson, Abbott Laboratories, and Genentech
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
It is a commonly occurring type of cancer. In the last few years this market has grown by leaps and bounds with the metastatic castrate-resistant prostate cancer (mCRPC) situation becoming more and more crowded and competitive.
Get a comprehensive overview of the Europe Prostate Cancer Market: http://marketdataforecast.com/market-reports/europe-prostate-cancer-market-1618/
Europe Prostate Cancer Market: Drivers & Restraints
Increasing number of prostate cancer cases, augmenting geriatric population, rising demand for novel drugs and growing number of unmet needs are the primary restraints of market growth.
Hefty treatment costs and low compliance rate from the patients because of the intricacy of treatments are the primary restraint of the market.
Get accurate market forecast and analysis on the Europe Prostate Cancer Market. Request a sample to stay up-to-date on the main trends affecting this market: http://marketdataforecast.com/market-reports/europe-prostate-cancer-market-1618/request-sample
Europe Prostate Cancer Market: Segmentation
By Diagnostic Techniques
• Digital Rectal Exam (DRE)
• Prostate Specific Antigen Test (PSA)
By Surgery
• Radical Prostatectomy
• Orchidectomy
• Trans Urethral Resection (TUR)
By Radiation Therapy
• External Beam Radiation Therapy
o 3D Conformal Radiation Therapy
o Intensity Modulated Radiation Therapy
o Stereotactic Body Radiation Therapy
o Proton Beam Radiation Therapy
• Brachytherapy
o Permanent Brachytherapy
o Temporary Brachytherapy
By Chemotherapy
• Docetaxel
• Etoposide
• Vinblastine
• Carboplatin
• Vinorelbine
By Geography
• Europe
o China
o India
o Japan
o Australia
o South Korea
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://marketdataforecast.com/market-reports/europe-prostate-cancer-market-1618/customize-report
Europe Prostate Cancer Market: Overview
By radiation therapy, External Beam Radiation Therapy is the market leader and is expected to remain so in the aforementioned period.
Europe is the second largest market in the world. Germany is the market leader accounting for the largest market share and is expected to remain so in the aforementioned forecast period.
Europe Prostate Cancer Market: Key Players
Key players in the market include Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer. Other players in the market include Johnson & Johnson, Abbott Laboratories, and Genentech
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results